Clinical trial

ABO-GLYC in Type 2 Diabetes

NCT03568409

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2017-06-01

PhaseNA

Study timeline

Study start (actual)2017-06-01Date precision: day

Registry last updated2022-06-30

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type2 Diabetesunresolved

Interventions

ABO-GLYCDEVICE

ABO-GLYC PlaceboOTHER

Sponsors & collaborators

Aboca Spa Societa' Agricolalead sponsor

Latis S.r.l.collaborator

Fondazione Edmund Machcollaborator

Mapped research locations

PadovaItaly1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03568409 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.